相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
Paul M. O'Byrne et al.
LANCET RESPIRATORY MEDICINE (2021)
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
Liam G. Heaney et al.
LANCET RESPIRATORY MEDICINE (2021)
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index
P. Jane McDowell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma A Delphi Study
Carey M. Suehs et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
The Patients' Experience of Severe Asthma Add- On Pharmacotherapies: A Qualitative Descriptive Study This
Vanessa L. Clark et al.
JOURNAL OF ASTHMA AND ALLERGY (2021)
What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Vanessa L. Clark et al.
ERJ OPEN RESEARCH (2021)
Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
Eugene R. Bleecker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Fernando Holguin et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Characterization of Severe Asthma Worldwide Data From the International Severe Asthma Registry
Eileen Wang et al.
CHEST (2020)
Rational oral corticosteroid use in adult severe asthma: A narrative review
Li Ping Chung et al.
RESPIROLOGY (2020)
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S. Harvey et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
Bruno Sposato et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Severe Asthma Toolkit: an online resource for multidisciplinary health professionals-needs assessment, development process and user analytics with survey feedback
Steven Maltby et al.
BMJ OPEN (2020)
Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives
Mark Hew et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
David Price et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Guidance for the prevention and emergency management of adult patients with adrenal insufficiency
Helen Simpson et al.
CLINICAL MEDICINE (2020)
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
Tim Harrison et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia
Mark Hew et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
Jaco Voorham et al.
ALLERGY (2019)
... I've said I wish I was dead, you'd be better off without me: A systematic review of people's experiences of living with severe asthma
Daniela Eassey et al.
JOURNAL OF ASTHMA (2019)
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
Vanessa M. McDonald et al.
RESPIROLOGY (2019)
Time to FOCUS on oral corticosteroid stewardship in asthma management
Claire N. McBrien et al.
RESPIROLOGY (2019)
Update in Asthma and Airway Inflammation 2018
Andrew Menzies-Gow et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
Sandhya Khurana et al.
CLINICAL THERAPEUTICS (2019)
Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis
Sarah A. Hiles et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study
Cristina Ardura-Garcia et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Observational cohort study to investigate the unmet need and time waiting for referral for specialist opinion in adult asthma in England (UNTWIST asthma)
John D. Blakey et al.
BMJ OPEN (2019)
Mechanisms and Management of Asthma Exacerbations
J. Michael Ramsahai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
Jonathan Steinfeld et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
Andrew Menzies-Gow et al.
ERJ OPEN RESEARCH (2019)
Exacerbation risk and characterisation of the UK's asthma population from infants to old age
Chloe I. Bloom et al.
THORAX (2018)
Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma A Systematic Review and Meta-analysis
Diana M. Sobieraj et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma A Systematic Review and Meta-analysis
Diana M. Sobieraj et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Oral corticosteroid exposure and adverse effects in asthmatic patients
Patrick W. Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Combined Analysis of Asthma Safety Trials of Long-Acting beta(2)-Agonists
William W. Busse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations
Tricia McKeever et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations
D. J. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma
Enrico Heffler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR)
Christer Janson et al.
RESPIRATORY RESEARCH (2018)
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
David B. Price et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Eli M. Miloslavsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
I have lost in every facet of my life: the hidden burden of severe asthma
Juliet M. Foster et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Mortality: a neglected outcome in OCS-treated severe asthma
Arnaud Bourdin et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies
Geoffrey Chupp et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Management of severe asthma: targeting the airways, comorbidities and risk factors
Peter G. Gibson et al.
INTERNAL MEDICINE JOURNAL (2017)
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial
Ashley Woodcock et al.
LANCET (2017)
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G. Gibson et al.
LANCET (2017)
Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study
Helen K. Reddel et al.
LANCET (2017)
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Multidimensional assessment of severe asthma: A systematic review and meta-analysis
Vanessa L. Clark et al.
RESPIROLOGY (2017)
Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community
Ruth Costello et al.
BMJ OPEN (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative
John D. Blakey et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma
Robert S. Zeiger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
A Structured Approach to Specialist-referred Difficult Asthma Patients Improves Control of Comorbidities and Enhances Asthma Outcomes
Tunn Ren Tay et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis
L. E. Barry et al.
RESPIRATORY RESEARCH (2017)
Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma
Wanda Phipatanakul et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Prioritizing Systemic Corticosteroid Treatments to Mitigate Relapse in Adults With Acute Asthma: A Systematic Review and Network Meta-analysis
Brian H. Rowe et al.
ACADEMIC EMERGENCY MEDICINE (2017)
A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use
Akke-Nynke van der Meer et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
P. G. Gibson et al.
INTERNAL MEDICINE JOURNAL (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Joan Sweeney et al.
THORAX (2016)
Targeted therapeutics for severe refractory asthma: monoclonal antibodies
Christopher L. Grainge et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
Anand A. Dalal et al.
Journal of Managed Care & Specialty Pharmacy (2016)
Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use
James L. Zazzali et al.
ALLERGY AND ASTHMA PROCEEDINGS (2015)
Dedicated Severe Asthma Services Improve Health-care Use and Quality of Life
David Gibeon et al.
CHEST (2015)
Acute and chronic systemic corticosteroid-related complications in patients with severe asthma
Patrick Lefebvre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
Leonie H. A. Broersen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents
Gustavo J. Rodrigo et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2015)
Adjusting prednisone using blood eosinophils reduces exacerbations and improves asthma control in difficult patients with asthma
Peter A. B. Wark et al.
RESPIROLOGY (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study
Vanessa Cooper et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2015)
Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis
Astrid L. Voskamp et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales
Michael E. Hyland et al.
QUALITY OF LIFE RESEARCH (2015)
The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
Stephen O'Neill et al.
THORAX (2015)
Adrenal insufficiency
Evangelia Charmandari et al.
LANCET (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anxiety, depression and personality traits in severe, prednisone-dependent asthma
Marijke Amelink et al.
RESPIRATORY MEDICINE (2014)
Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
Guy G. Brusselle et al.
THORAX (2013)
Prevalence of Bronchiectasis in Asthma according to Oral Steroid Requirement: Influence of Immunoglobulin Levels
Manel Lujan et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Adult Asthma and Risk of Coronary Heart Disease, Cerebrovascular Disease, and Heart Failure: A Prospective Study of 2 Matched Cohorts
Carlos Iribarren et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Moderate Dose Inhaled Corticosteroid-Induced Symptomatic Adrenal Suppression: Case Report and Review of the Literature
Richard H. Schwartz et al.
CLINICAL PEDIATRICS (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry
Joan Sweeney et al.
THORAX (2012)
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
Nicola A. Hanania et al.
ANNALS OF INTERNAL MEDICINE (2011)
Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis
Ceire Costelloe et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
Jerry A. Krishnan et al.
AMERICAN JOURNAL OF MEDICINE (2009)
CURRENT CONCEPTS Predisposing Factors for Adrenal Insufficiency
Stefan R. Bornstein
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Electronic antibiotic stewardship - reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting
K. L. Buising et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone
Jean Bousquet et al.
RESPIRATORY MEDICINE (2007)
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Wendy C. Moore et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Complementary therapy use by patients and parents of children with asthma and the implications for NHS care: a qualitative study
Alison Shaw et al.
BMC HEALTH SERVICES RESEARCH (2006)
Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes
VE Murphy et al.
THORAX (2006)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
Corticosteroid therapy for acute asthma
BH Rowe et al.
RESPIRATORY MEDICINE (2004)
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial
TW Harrison et al.
LANCET (2004)
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
B Abraham et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
RA Pauwels et al.
LANCET (2003)
Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma
AM Jones et al.
RESPIRATORY MEDICINE (2002)
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma
S Suissa et al.
THORAX (2002)
Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study
T Hasegawa et al.
INTERNAL MEDICINE (2000)
Low-dose inhaled corticosteroids and the prevention of death from asthma.
S Suissa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)